Effectiveness of Chemotherapy for Advanced Lung Cancer in the Elderly: Instrumental Variable and Propensity Analysis
- 15 February 2001
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 19 (4), 1064-1070
- https://doi.org/10.1200/jco.2001.19.4.1064
Abstract
PURPOSE: To compare the effectiveness of chemotherapy given to elderly patients in routine practice for stage IV non–small-cell lung cancer (NSCLC) with the efficacy observed in randomized trials. PATIENTS AND METHODS: We used instrumental variable analysis (IVA) and propensity scores (PS) to simulate the conditions of a randomized trial in a retrospective cohort of patients over age 65 from the Survival, Epidemiology, and End Results (SEER) tumor registry. Geographic variation in chemotherapy use served as the instrument for the IVA analysis, and propensity scores were calculated with a logistic model based on patient disease and sociodemographic characteristics. RESULTS: Among 6,232 elderly patients, the instrumental variable estimate indicated an increase in median survival of 33 days and an improvement in 1-year survival of 9% attributable to chemotherapy. In a Cox regression model, chemotherapy administration was associated with a hazard ratio of 0.81 (95% confidence interval, 0.76 to 0.85). When survival was analyzed separately within propensity score quintiles, the hazard ratios were all similar, ranging from 0.78 to 0.85. These results are comparable with those of a large meta-analysis, which found a hazard ratio of 0.87 in the subgroup of patients over age 65. CONCLUSION: Chemotherapy for stage IV NSCLC seems to have effectiveness for elderly patients and those with comorbid conditions that is similar to the efficacy seen in randomized trials containing mostly younger, highly selected patients. All suitable patients should be given the opportunity to consider palliative chemotherapy for metastatic NSCLC.Keywords
This publication has 26 references indexed in Scilit:
- Who Gets Chemotherapy for Metastatic Lung Cancer?Social psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2000
- Women's participation in rural credit programmes in Bangladesh and their demand for formal health care: is there a positive impact?1Health Economics, 1999
- Managed care, consolidation among health care providers, and health care: evidence from mammography.The RAND Journal of Economics, 1999
- More physicians: improved availability or induced demand?Health Economics, 1998
- ECONOMETRICS IN OUTCOMES RESEARCH: The Use of Instrumental VariablesAnnual Review of Public Health, 1998
- Volume responses to medicare payment reductions with multiple payers: a test of the McGuire-Pauly modelHealth Economics, 1998
- Using administrative databases to evaluate long-term care.Journal of the American Geriatrics Society, 1997
- Variation in the Use of Cardiac Procedures after Acute Myocardial InfarctionThe New England Journal of Medicine, 1995
- Does More Intensive Treatment of Acute Myocardial Infarction in the Elderly Reduce Mortality?JAMA, 1994
- Chemotherapy of Lung CancerThe New England Journal of Medicine, 1992